DRUG · Unmapped registry intervention
Pirarubicin
Find medicine records ·
Find other trials using this name
Clinical trial
Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer
NCT02613026
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Cyclophosphamide
Normalized identity: cyclophosphamideView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedComparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Neoplasmsunresolved
Interventions
PirarubicinDRUG
DocetaxelDRUG · verified · RxNorm: docetaxel
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
Sponsors & collaborators
307 Hospital of PLAlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02613026 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.